Share this
Cell Design Labs Sells to Gilead
Versartis $145 Million IPO
Principia Biopharma – $122 Million IPO
DBV Technologies Completes Concurrent Public Offerings
Aduro Completes $137 Million IPO
Bristol Meyers Enters Agreement with Five Prime
Avidity Biosciences Licensing and Research Collaboration with Eli Lilly
Medivation Agrees to Sell to Pfizer for $14 Billion
Genocea Biosciences IPO
Atreca - $125 Million IPO
NGM Biopharmaceuticals - $107 Million IPO
Alpine Immune Sciences in its Collaboration and License Agreement with Adaptimmune
23andMe in its Multi-year Collaboration with GSK
Adaptive Biotechnologies Announces Strategic Collaboration with Genentech
Arcus Biosciences Announces 10-year Partnership with Gilead